On ECHEMI
Home > Drugs > Quetiapine Fumarate Tablets

Quetiapine Fumarate Tablets

Function and Efficacy

Not yet clear.

Ingredients

The main ingredient of this product is: Quetiapine fumarate.

Name Description Content CAS NO. Manufacturer
Quetiapine fumarateIngredients

Not yet clear

More
111974-72-2 111

Appearance

This product is a round, pink tablet.

Indication

Used to treat schizophrenia.

Usage and Dosage

The drug is administered twice daily, either before or after meals. The total daily dose for adults during the first 4 days of treatment is 50 mg (first day), 100 mg (second day), 200 mg (third day) and 300 mg (fourth day). After the fourth day, the dose is gradually increased to the effective dose range, generally 300-450 mg/day. The dose can be adjusted between 150-750 mg/day according to the patient's clinical response and tolerance.

Adverse Reactions

Not yet clear.

Precautions

It is contraindicated for those who are allergic to this product.

Special Population Medication

Precautions for children: The safety and efficacy of this product for children and adolescents have not been evaluated. Precautions for pregnancy and lactation: The efficacy and safety of this product for human pregnancy have not been confirmed (for reproductive toxicity data on animals, see the reproductive studies section of the preclinical case data section). Therefore, "Seroquel" can only be used in pregnant patients when the benefits outweigh the potential risks. The excretion of quetiapine in human milk is not yet clear. If a lactating woman takes quetiapine, she should be advised to discontinue breastfeeding during the medication. Precautions for the elderly: Like other antipsychotic drugs, it should be used with caution in the elderly, especially when starting the medication. The starting dose for the elderly should be 25 mg/day. Increase the dose daily by 25-50 mg until the effective dose is reached. The effective dose may be lower than that of an average young patient.

Drug Interactions

Because quetiapine has primarily CNS effects, caution should be exercised when used in combination with other centrally acting drugs or alcohol.

Storage

Keep tightly closed.

Packaging Specification

0.3g

Validity Period

36 months

Manufacturer

Suzhou First Pharmacertical Co., Ltd.

  • Founded in:

    2005-12-23
  • Address:

    No. 1 Hualing Street, Suzhou Industrial Park
  • Tax NO.:

    91320594783360722P
  • Registered Funds:

    181.625 million yuan
  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.